EPIENDO PHARMACEUTICALS
EpiEndo is a clinical-stage biopharmaceutical company with a unique approach to inflammatory disorders that focuses on the enhancement of epithelial barrier integrity as a causal pathophysiological factor underlying the etiology of a number of major diseases. Epithelial cells are a key component of the barrier that makes up human skin and lung tissue, as well as the intestinal tract and genitalia. Compromised integrity of this barrier is implicated in the progression and non-resolution of inflam... mation. EpiEndo is developing a proprietary portfolio of orally available macrolide drug candidates with promise as first-in-class disease-modifying therapeutics, to address the huge global burden of chronic respiratory diseases and other significant unmet medical needs. EpiEndo’s lead drug candidate, EP395, aims to be the first on-market oral, disease modifying, non-antibiotic, barrier strengthening and anti-inflammatory macrolide for COPD and other inflammatory airway diseases.
EPIENDO PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
2014-01-01
Address:
ReykjavÃk, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.epiendo.com
Total Employee:
1+
Status:
Active
Contact:
00 354 454 0090
Email Addresses:
[email protected]
Total Funding:
33.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Organization Schema Microsoft Azure DNS
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Urovant Sciences
Urovant Sciences is a global biopharmaceutical company focused on developing novel therapies for urologic conditions.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kvika Asset Management
Kvika Asset Management investment in Series A - EpiEndo Pharmaceuticals
ABC Ventures
ABC Ventures investment in Series A - EpiEndo Pharmaceuticals
Flerie Invest
Flerie Invest investment in Series A - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Series A - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Debt Financing - EpiEndo Pharmaceuticals
ABC Ventures
ABC Ventures investment in Seed Round - EpiEndo Pharmaceuticals
Icelandic Startups
Icelandic Startups investment in Seed Round - EpiEndo Pharmaceuticals
European Innovation Council
European Innovation Council investment in Grant - EpiEndo Pharmaceuticals
Brunnur Ventures
Brunnur Ventures investment in Angel Round - EpiEndo Pharmaceuticals
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - EpiEndo Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-24 | EpiEndo Pharmaceuticals Expands its Leadership Team, Appointing Stefan Petursson as Chief Financial Officer to Support Future Growth |
Official Site Inspections
http://www.epiendo.com Semrush global rank: 9.42 M Semrush visits lastest month: 160
- Host name: pisi.stefna.is
- IP address: 52.49.138.181
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "EpiEndo Pharmaceuticals"
EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals was founded on the knowledge that azithromycin reduces exacerbations of COPD and other respiratory diseases, effects that go beyond its antibacterial …See details»
EpiEndo Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. EpiEndo Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... EpiEndo’s lead drug candidate, …See details»
Investors | EpiEndo Pharmaceuticals
Welcome to EpiEndo Pharmaceuticals’ Investor Page. We are a clinical-stage biopharmaceutical company focused on developing innovative therapies for chronic respiratory diseases. Based on over 20 years of research into …See details»
EpiEndo Pharmaceuticals - Funding, Financials, Valuation & Investors
EpiEndo Pharmaceuticals is a clinical biopharmaceutical company focused on novel solutions for chronic airway diseases. New. Resources. Advanced Search. ... How much funding has this …See details»
EpiEndo Pharmaceuticals ehf - Drug pipelines, Patents ... - Patsnap
Explore EpiEndo Pharmaceuticals ehf with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 14 news, and 7 literature, Technology Platform:Small molecule drug, …See details»
EpiEndo - NAVA
EpiEndo is a clinical stage pharmaceutical company developing a proprietary portfolio of therapies to address the huge global burden of chronic respiratory diseases. With more than a decade of research into COPD, the team behind …See details»
EpiEndo Pharmaceuticals | VentureRadar
EpiEndo is a clinical stage pharmaceutical company developing a proprietary portfolio of drugs to address the huge global burden of chronic respiratory diseases. Over more than a decade our …See details»
EpiEndo - explore.openaire.eu
Organization, country, EpiEndo, EpiEndo Pharmaceuticals ehfSee details»
EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals is founded on the hypothesis that acute exacerbations of chronic airway diseases (CADs) are primarily triggered by insults to the epithelial barrier of the airways. As a …See details»
EpiEndo Pharmaceuticals ehf:Company Profile & Technical …
EpiEndo Pharmaceuticals is a company that provides Health care, Virtual organization, Airway disease and more. EpiEndo Pharmaceuticals is headquartered in Iceland Gullbringusysla. …See details»
www.epiendo.com
EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company developing novel non-antibiotic macrolide therapeutics for the treatment of inflammatory disorders, announced today …See details»
EpiEndo Pharmaceuticals ehf:News,Events,Trend Of News
Discovery Company profile page for EpiEndo Pharmaceuticals ehf including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
EpiEndo Pharmaceuticals: Innovative Solutions for Chronic Care
EpiEndo Pharmaceuticals pioneers fresh approaches in chronic care, developing treatments that address the root causes of chronic diseases to improve long-term patient health. Industry. …See details»
EpiEndo and AlveoliX Update on Partnership to Pioneer Ulcerative ...
Jun 4, 2024 REYKJAVIK, ICELAND & BERN, SWITZERLAND – 4 June 2024 – EpiEndo Pharmaceuticals (‘EpiEndo’), a clinical-stage biopharmaceutical company leading in epithelial …See details»
News & Events | EpiEndo Pharmaceuticals
Dec 17, 2024 EpiEndo Pharmaceuticals: Maria Bech, CEO +354 454 0090 Vigo Consulting (media relations): Rozi Morris +44 20 7390 0230 [email protected]. About …See details»
EpiEndo and AlveoliX achieve milestone in ulcerative colitis …
Jun 4, 2024 EpiEndo Pharmaceuticals, a clinical-stage biopharmaceutical company, and AlveoliX, an innovator in organ-on-chip technology, have announced significant advancements …See details»
AlveoliX and EpiEndo Update on Partnership to Pioneer Ulcerative ...
Key achievements include: ☑ EpiEndo’s Barriolideâ„¢, Enterothelin, has emerged as a promising first-in class therapy to address the underlying cause of UC. ☑ AlveoliX has developed a new …See details»
XOENDO - XOENDO
In spring 2024, nearly half (45%) of Canadians reported that rising prices were greatly affecting their ability to meet day-to-day expenses, 12 percentage points higher than what it was two …See details»
News & Events | EpiEndo Pharmaceuticals
EpiEndo, in collaboration with the University of Iceland, have also received a 3 year Practical Research Project grant from the Technology Development Fund. RANNÍS supports the …See details»
News & Events | EpiEndo Pharmaceuticals
EpiEndo Pharmaceuticals has received regulatory and ethics approval to commence a Lipopolysaccharide (LPS) challenge clinical trial with lead molecule EP395. EP395 is an orally …See details»